Successful treatment of pure red cell aplasia with high-dose dexamethasone after ABO-incompatible allogeneic hematopoietic stem cell transplantation

The literature reports an incidence of Pure Red Cell Aplasia (PRCA) ranging from 6-30% of all cases of ABO-incompatible HSCT. Although most patients resolve spontaneously after withdrawal immunosuppression, some of them require more aggressive treatment to manage this condition.

Библиографические подробности

Главные авторы:	Rosario Varela Gómez, Goretti Vázquez Vázquez, Victor Noriega Concepción, Andrea Galego García, Concepción Andón Saavedra
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Wolters Kluwer Medknow Publications 2018-01-01
Серии:	Hematology/Oncology and Stem Cell Therapy
Предметы:	pure red cell aplasia aplastic anemia hematopoietic stem cell transplantation dexamethasone
Online-ссылка:	https://journals.lww.com/10.1016/j.hemonc.2017.08.004
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!